Jose Manuel Valdivielso Revilla
Grau: Doctor/a
973 702 952
valdivielso(ELIMINAR)@irblleida.cat
ResearcherID: http://www.researcherid.com/rid/B-5673-2009
Publicacions
-
Vila MDM; Remeseiro B; Igual L; Elosua R; Ramos R; Valdivielso JM; Martí-Lluch R; Marrugat J; Grau M
Do individuals with autoimmune disease have increased risk of subclinical carotid atherosclerosis and stiffness?
HYPERTENSION RESEARCH 44 978-987. .
-
Del Mar Vila M; Remeseiro B; Igual L; Elosua R; Ramos R; Valdivielso JM; Martí-Lluch R; Marrugat J; Grau M
Correction: Do individuals with autoimmune disease have increased risk of subclinical carotid atherosclerosis and stiffness?
HYPERTENSION RESEARCH 44 1046-1046. .
-
Saumoy, M; Di Yacovo, S; Perez, S; Sanchez-Quesada, JL; Valdivielso, JM; Subirana, I; Imaz, A; Tiraboschi, JM; Garcia, B; Ordonez-LLanos, J; Benitez, S; Podzamczer, D; Grau, M
Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations
HIV MEDICINE 22 581-591. .
-
Bozic, Milica; Diaz-Tocados, Juan M.; Bermudez-Lopez, Marcelino; Forne, Carles; Martinez, Cristina; Fernandez, Elvira; Valdivielso, Jose M.
Independent effects of secondary hyperparathyroidism and hyperphosphatemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort.
NEPHROLOGY DIALYSIS TRANSPLANTATION 37 1-10. .
-
Rodrigues-Diez, RR; Tejera-Munoz, A; Orejudo, M; Marquez-Exposito, L; Santos, L; Rayego-Mateos, S; Cantero-Navarro, E; Tejedor-Santamaria, L; Marchant, V; Ortiz, A; Egido, J; Mezzano, S; Selgas, R; Navarro-Gonzalez, JF; Valdivielso, JM; Lavoz, C; Ruiz-Ortega, M
Interleukin-17A: Potential mediator and therapeutic target in hypertension.
Nefrologia 41 244-257. .
-
Fernandez, LM; Sanchez-Alvarez, JE; de la Tassa, CM; Fernandez, JJB; Maria, V; Fernandez, E; Valdivielso, JM; Betriu, A
Risk factors associated with valvular calcification in patients with chronic kidney disease. Analysis of NEFRONA study
Nefrologia 41 337-346. .
-
Kosanovic M; Llorente A; Glamoclija S; Valdivielso JM; Bozic M
Extracellular Vesicles and Renal Fibrosis: An Odyssey toward a New Therapeutic Approach.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 -. .
-
Del Vecchio, L; Ekart, R; Ferro, CJ; Malyszko, J; Mark, PB; Ortiz, A; Sarafidis, P; Valdivielso, JM; Mallamaci, F; ERA-EDTA European Renal and Cardiovascular Medicine Working (EURECA-m) Group
Intravenous iron therapy and the cardiovascular system: risks and benefits.
CLINICAL KIDNEY JOURNAL 14 1067-1076. .
-
Gorriz JL; Arroyo D; D'Marco L; Torra R; Tomás P; Puchades MJ; Panizo N; Pantoja J; Montomoli M; Llisterri JL; Pallares-Carratalá V; Valdivielso JM
Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease.
BMC NEPHROLOGY 22 110-110. .
-
Sánchez M; Sánchez E; Bermúdez-López M; Torres G; Farràs-Sallés C; Pamplona R; Castro-Boqué E; Valdivielso JM; Purroy F; Martínez-Alonso M; Godoy P; Mauricio D; Fernández E; Hernández M; Rius F; Lecube A
Clinical Usefulness of Anthropometric Indices to Predict the Presence of Prediabetes. Data from the ILERVAS Cohort.
Nutrients 13 1-15. .
-
Sapiña-Beltrán E; Gracia-Lavedan E; Torres G; Gaeta AM; Paredes J; Mayoral A; Fernández E; Bermúdez-López M; Valdivielso JM; Farràs-Salles C; Pamplona R; Lecube A; de Batlle J; Barbé F; Dalmases M
Prevalence of Obstructive Sleep Apnoea and Its Association With Atherosclerotic Plaques in a Cohort of Subjects With Mild-Moderate Cardiovascular Risk.
ARCHIVOS DE BRONCONEUMOLOGIA 58 490-497. .
-
Mark PB; Vecchio LD; Valdivielso JM; Malyszko J
Same rhythm, different song-approaches to atrial fibrillation management by cardiologists and nephrologists.
CLINICAL KIDNEY JOURNAL 14 9-13. .
Projectes
- Estancias de personal docente y/o investigador senior en centros extranjeros 2022
- El primer Estudio de asociación de genoma completo (GWAS) con enfermedad coronaria poblacional a 10 años en más de 100.000 participantes para personalizar la prevención cardiovascular en España
- Influence of SARS-COV-2 infection in atherosclerosis development. “El BUS DE LA SALUT” study
- SPAIN CKD CAUSE (SPACKDC)
- INVESTIGO 2022: Grup de recerca translacional vascular i renal
- Papel de PTEN en la reabsorcion tubular renal de proteinas. Implicaciones en nefropatias proteinuricas
- Preservació la membrana peritoneal abordant noves vies per inhibir la transició mesotelio-mesenquimal.
- Acciones de Dinamización "Europa Investigación 2020"
- Contratos Sara Borrell
- Papel de la vía PI3K/AKT/mTOR en la regulación de las alteraciones del metabolismo mineral en la enfermedad renal crónica. Implicaciones en la regulación de la síntesis de FGF23.
- Ajuts destinats a contractar personal investigador novell (FI)
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA CIENTIFICA BASICA PER A LA CARACTERITZACIO D'UN PERFIL LIPIDOMICO Y LIPIDICO DE RIESGO ATEROGENERICO Y DE MORBIMORTALIDAD CARDIOVASCUAL EN LA ENFERMEDAD RENAL CRONICA (ESTADIOS 3 A 5), ESTUDIO PROSPECTIVO NEFRONA.